Drug · DIN 02543036
JAMTEKI
SINGLE-USE VIAL AND PREFILLED SYRINGE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since March 1, 2024; first marketed March 1, 2024.
- Drug Identification Number (DIN)
- 02543036
- Company (DIN owner)
- JAMP Pharma CorporationBoucherville, Quebec, Canada
- Schedule
- Prescription; Schedule d
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Ustekinumab L04AC05
- Class
- Human
- Record last updated
- August 13, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| USTEKINUMAB | 45 MG | 0.5 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 15, 2023: NOC 32124New Drug Submission (NDS)
Other DINs named JAMTEKI
- DIN 02543044 · Marketed